Safety and efficacy of lobeglitazone monotherapy in patients with type 2 diabetes mellitus over 52 weeks: An open-label extension study

  • Sun Hwa Kim
  • , Sin Gon Kim
  • , Doo Man Kim
  • , Jeong Taek Woo
  • , Hak Chul Jang
  • , Choon Hee Chung
  • , Kyung Soo Ko
  • , Jeong Hyun Park
  • , Yong Soo Park
  • , Sang Jin Kim
  • , Dong Seop Choi*
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Safety and efficacy of lobeglitazone monotherapy in patients with type 2 diabetes mellitus over 52 weeks: An open-label extension study'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science